Anzeige
❌
Mehr »
Freitag, 20.11.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2DJR2 | ISIN: SE0009268717 | Ticker: 7AC
Frankfurt
20.11.26 | 08:08
0,008 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ACARIX AB Chart 1 Jahr
5-Tage-Chart
ACARIX AB 5-Tage-Chart

Aktuelle News zur ACARIX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
05.11.Acarix AB: Acarix Publishes Third Quarter 2026 Results126Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the third quarter of 2026. The quarter delivered the highest revenue...
► Artikel lesen
08.10.Acarix AB: Acarix Provides Update on RHTP and Saudi Arabia Regulatory Process285Acarix has received several inquiries from shareholders regarding the status of the U.S. Rural Health Transformation Program (RHTP) and regulatory approval in the Kingdom of Saudi Arabia (KSA) and would...
► Artikel lesen
11.09.Acarix AB: Peer-Reviewed Study Confirms CADScor System Can Diagnose Heart Failure With Far Fewer False Positives Than Standard Blood Test486Aalborg University-led research, published in PLOS Digital Health, found the CADScor System's acoustic sensing platform identified heart failure with diagnostic accuracy comparable to a leading blood...
► Artikel lesen
13.08.Acarix AB Q2 Sales Increase10
13.08.Earnings Call: Acarix meldet starkes Wachstum für Q2 2026, doch die Aktie gibt nach10
13.08.Acarix Q2 2026 slides: revenue doubles as US growth accelerates1
13.08.Acarix Q2 2026 slides: US revenue surges 212%, losses narrow5
ACARIX Aktie jetzt für 0€ handeln
13.08.Acarix AB: Acarix Publishes Second Quarter and First Half 2026 Results286Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the second quarter and first half 2026. The report highlights continued commercial...
► Artikel lesen
17.06.Acarix AB: Announcement from the annual general meeting in Acarix AB331The annual general meeting 2026 (the "AGM") of Acarix AB ("Acarix" or the "Company") was held today on 17 June 2026 and the following resolutions were passed by the meeting. Adoption of the income statement...
► Artikel lesen
18.05.Acarix AB: Acarix Publishes Interim Report, January - March 2026369Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its interim financial results for the first quarter of 2026. The report highlights meaningful progress across the...
► Artikel lesen
12.02.Acarix AB: Acarix Publishes Year-End Report 2025365Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end financial results. "Last year was a year of meaningful commercial and operational...
► Artikel lesen
11.02.Acarix AB: Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System594Malmö, Sweden - Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics for coronary artery disease, today announced that it has entered into a strategic...
► Artikel lesen
04.02.Acarix AB: Acarix Receives EU MDR Certification for the CADScorSystem467Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor System has successfully achieved certification under the European Union Medical...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1